Anus Neoplasms: all 269 studies
Page 1 of 3. Open to participants first (72), then studies with results posted, then the rest; newest registration first within each.
- Epidemiology of Anal Human Papillomavirus Carriage in Female Solid Organ Transplant Recipients With More Than 10 Years of ImmunosuppressionNot yet recruitingNCT07858201Not applicable
- Mind-Body Sexual Well-Being Program for Female GI Cancer SurvivorsNot yet recruitingNCT07795801Not applicable
- Swabs in Screening for HPV (SWISH)Not yet recruitingNCT07790601Not applicable
- Irreversible Electroporation (IRE) for Treating Recurrent Pelvic Tumors (PELFIRE Study)RecruitingNCT07782164
- Shortening Radiation Course Duration Using Simultaneous Integrated Boost With Lower Intensity Elective Nodal Dosing and Concurrent Chemotherapy for High-Risk Anal Squamous Cell CarcinomaEnrolling by invitationNCT07775209Phase 2
- Disease Evolution and Risk Factors of AIDS-related Prevalent CancersNot yet recruitingNCT07696169
- Sintilimab Versus Mitomycin in Combination With Capecitabine and IMRT for Limited-stage Anal Squamous Cell CarcinomaRecruitingNCT07692152Phase 3
- Phase 2 Study of Pembrolizumab and Lenvatinib in Anal Squamous Cell CancerNot yet recruitingNCT07680088Phase 2
- COQ10 and Vitamin E for Off-Target Radiation ToxicityNot yet recruitingNCT07668284Phase 1/2
- A Study of IDP-001 in Advanced or Metastatic Solid TumorsRecruitingNCT07602842Phase 1/2
- Chemoradiotherapy and Anti-PD-1 Antibody in Anal Squamous Cell Cancer：ChaseRecruitingNCT07555678Phase 2
- Assessment of Sexual Quality of Life Following Local Treatment (Radiotherapy With or Without Surgery) in Patients With HPV-positive Pelvic Cancer: a Descriptive Longitudinal StudyNot yet recruitingNCT07523152Not applicable
- Improving Clinic Delivery of HIV-related Anal Health ServicesNot yet recruitingNCT07464236Not applicable
- ctHPVDNA Response-Adapted Chemoradiation +/- Retifanlimab Treatment in Locally-Advanced Anal CancerRecruitingNCT07425054Phase 2
- Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal CancerRecruitingNCT07407647Phase 2
- Beyond Survival: Addressing Gynecological and Sexual Health in Women After Radiotherapy for Anal CancerRecruitingNCT07296237
- A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell CarcinomasRecruitingNCT07217171Phase 1
- Self-sampling to Optimize Anal Lesion OutcomesRecruitingNCT07192055Not applicable
- DESTINY-PANTUMOUR04RecruitingNCT07124000
- Ganglion Impar Neurolysis for the Improvement of Radiation-Induced Pain During Localized Anal or Perianal Skin Cancer TreatmentRecruitingNCT07112690Not applicable
- Distance-Based Exercise to Preserve Function and Prevent DisabilityRecruitingNCT07059884Not applicable
- Screening for Anal Cancer in Men Who Have Sex With Men Using Pre-Exposure ProphylaxisRecruitingNCT07029152Not applicable
- An Early Access Program Guideline to Provide Access to Retifanlimab (INCMGA00012) Together With Carboplatin and Paclitaxel for Squamous Carcinoma of the Anal Canal (SCAC)AvailableNCT06910137
- Ovarian-Sparing Adaptive Radiotherapy in Young Adult WomenRecruitingNCT06904365
- Host Genome Methylation: a Screening Tool in Anal Cancer DetectionRecruitingNCT06792604Not applicable
- HPV Genotype Attribution and Disease Burden of Anal Cancer in ChinaRecruitingNCT06670495
- HPV Infection and Vaginal Microecology in Immunosuppressed WomenNot yet recruitingNCT06619743
- Determining the Frequency of Occurrence and Defining the Most Appropriate Screening Test for Anal Intraepithelial Neoplasia (AIN) in Patients With Human Papillomavirus (HPV) Related Gynecological Diseases.RecruitingNCT06574087Not applicable
- Multidimensional Examination of Patients with Colorectal and Anal CancerRecruitingNCT06562140
- SCG142 TCR-T Cells for Human Papillomavirus-Associated CarcinomasRecruitingNCT06544720Phase 1
- Blood Biomarkers Based Screening for HPV-driven OPCNot yet recruitingNCT06528353Not applicable
- SMP-3124LP in Adults With Advanced Solid TumorsRecruitingNCT06526819Phase 1/2
- Identification of Molecular Signatures of High-risk Oncogenic HPV and Study of Their Associations With the Presence of High-grade Lesions and/or Anal Cancer 10 Years After Inclusion in the ANRS IPERGAY TrialRecruitingNCT06522256Not applicable
- Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal CancerRecruitingNCT06493019Phase 2
- Stigma and Psychological profilE in REctal-anal caNcer pAtientsRecruitingNCT06366841
- Patient Reported Outcomes (PROs) in Anal Cancer Patient Treated by Intensity Modulated Radiotherapy (IMRT).RecruitingNCT06364579
- CRTE7A2-01 TCR-T Cells for HPV-16 Positive Advanced CancersNot yet recruitingNCT06358053Phase 1
- Anal Cancer and/or Precancer Screening: Performance Analysis of the BD Onclarity™ HPV Assay on Anal SpecimensRecruitingNCT06327568
- A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid TumorsRecruitingNCT06270706Phase 1
- EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.RecruitingNCT06263088Not applicable
- Identification of the Pathogenetic Mechanisms Underlying Squamous Cell CarcinomasRecruitingNCT06236464
- Phase III Study Evaluating Induction Chemotherapy Followed by Chemoradiotherapy Compared to Standard Chemoradiotherapy for Locally Advanced SCCARecruitingNCT06207981Phase 3
- MR-Adaptive Radiation Therapy for Anal Cancer With EScalated-Treatment in a Risk-Optimized ApproachRecruitingNCT06050707Phase 2
- HRYZ-T101 Injection for HPV18 Positive Solid TumorRecruitingNCT05952947Phase 1
- A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid TumorsRecruitingNCT05941507Phase 1/2
- A Study Regarding Tissue Response During and After Treatment for Anal CancerRecruitingNCT05939401
- Adaptive Radiation in Anal CancerRecruitingNCT05838391Not applicable
- HRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid TumorRecruitingNCT05787535Phase 1
- E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated CancersRecruitingNCT05686226Phase 2
- Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related CancersRecruitingNCT05663502
- E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated CancersRecruitingNCT05639972Phase 1/2
- Human Papillomavirus in Young People Epidemiological Research 3RecruitingNCT05587725
- NOAC9 - Circulating Tumor DNA Guided Follow-Up in Anal CancerRecruitingNCT05572801Not applicable
- Re-optimization Based Online Adaptive Radiotherapy of Anal CancerRecruitingNCT05438836
- Chemoradiotherapy Combined With or Without PD-1 Blockade in Anal Canal Squamous Carcinoma PatientsRecruitingNCT05374252Phase 3
- Circulating Biomarkers in Patients With Anal Cancer Treated With Induction ChemotherapyRecruitingNCT05233540
- Screening Women With Prior HPV for Anal NeoplasiaRecruitingNCT05217940Not applicable
- Pencil Beam Proton Therapy for Recurrences in Anal Cancer Patients Previously Treated With Radiotherapy (DACG 5)RecruitingNCT05055635Phase 2
- Virtual Reality for GI Cancer Pain to Improve Patient Reported OutcomesRecruitingNCT04907643Not applicable
- Combination of Spartalizumab, mDCF and Radiotherapy in Patients With Metastatic Squamous Cell Anal CarcinomaRecruitingNCT04894370Phase 2
- Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent TumorsNot yet recruitingNCT04889742Phase 2
- Detecting HPV DNA in Anal and Cervical CancersRecruitingNCT04857528
- ANCA II - Quality of Life and Functional Outcome in Patients With Anal CancerRecruitingNCT04792892
- Proton Versus Photon Therapy in Anal Squamous Cell CarcinomaRecruitingNCT04462042Not applicable
- Radiation Therapy for the Treatment of Metastatic Gastrointestinal CancersRecruitingNCT04221893Not applicable
- Intrafractional Vaginal Dilation in Anal Cancer Patients Undergoing Pelvic RadiotherapyRecruitingNCT04094454Not applicable
- Deciphering Mechanisms Underlying Cancer ImmunogenicityRecruitingNCT03958240Not applicable
- HPV-SAVE_Merck_Sub-Study for Preventing Recurrence of HSILNot yet recruitingNCT03947775Phase 2
- Prospective Observational Trial to Evaluate Quality of Life After Definitive Chemoradiation in Patients With Anal Cancer (LANACARE)RecruitingNCT03792854
- Seville Cohort of People Living With HIV at Risk for Anal CancerEnrolling by invitationNCT03713229
- Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer.RecruitingNCT03061435Not applicable
- Integrated Cancer Repository for Cancer ResearchRecruitingNCT02012699
- The Self-Sampling Pilot StudyCompletedNCT07085845Not applicableResults posted
- Open Pilot Trial of a Mind-Body Sexual Well-Being Intervention for Female GI Cancer SurvivorsCompletedNCT06331403Not applicableResults posted
- A Chatbot Intervention for Reducing HPV Vaccine HesitancyCompletedNCT05959564Not applicableResults posted
- A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid TumorsTerminatedNCT05551117Phase 2Results posted
- Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMCCompletedNCT05510908Results posted
- Efficacy, Immunogenicity, and Safety Study of V503 (9-valent Human Papillomavirus [9vHPV] Vaccine) in Japanese Males (V503-064)CompletedNCT04635423Phase 3Results posted
- Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal CancerCompletedNCT04505553Phase 2Results posted
- Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2).CompletedNCT04472429Phase 3Results posted
- HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated CancersCompletedNCT04432597Phase 1/2Results posted
- Combination Immunotherapy in Subjects With Advanced HPV Associated MalignanciesCompletedNCT04287868Phase 1/2Results posted
- Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid TumorsTerminatedNCT04234113Phase 1Results posted
- The Prevent Anal Cancer Palpation StudyCompletedNCT04090060Not applicableResults posted
- Sacral Nerve Stimulation in Treating Low Anterior Resection Syndrome or Fecal Incontinence in Patients With Locally Advanced Rectal Cancer or Other Pelvic Cancer, the RESTORE StudyTerminatedNCT04066894Phase 2Results posted
- SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or LymphomasCompletedNCT03894618Phase 1Results posted
- A Message Framing Intervention for Increasing Parental Acceptance of Human Papillomavirus VaccinationCompletedNCT03856437Not applicableResults posted
- Linear Energy Transfer (LET)-Optimized Intensity Modulated Proton Therapy (IMPT) as a Component of Definitive Chemoradiation for Newly Diagnosed Squamous Cell Carcinoma of the Anal Canal: a Feasibility TrialCompletedNCT03690921Phase 2Results posted
- VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HPV-18 Related Anal or Anal/Peri-Anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative for Human Immunodeficiency Virus (HIV)-1/2CompletedNCT03499795Phase 2Results posted
- The Prevent Anal Cancer Self-Swab StudyCompletedNCT03489707Not applicableResults posted
- DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated CancersTerminatedNCT03439085Phase 2Results posted
- M7824 in Subjects With HPV Associated MalignanciesCompletedNCT03427411Phase 2Results posted
- Proton Therapy in Reducing Toxicity in Anal CancerActive, not recruitingNCT03018418Phase 2Results posted
- Pembrolizumab in Metastatic Anal CancerCompletedNCT02919969Phase 2Results posted
- Trial To Test Safety And Efficacy Of Vaccination For Incurable HPV 16-Related Oropharyngeal, Cervical And Anal CancerCompletedNCT02865135Phase 1/2Results posted
- Programs To Support You During ChemotherapyCompletedNCT02489422Not applicableResults posted
- Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryTerminatedNCT02408861Phase 1Results posted
- A Phase 2 Study of Axalimogene Filolisbac (ADXS11-001) in Participants With Carcinoma of the Anorectal CanalCompletedNCT02399813Phase 2Results posted
- Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal CancerActive, not recruitingNCT02314169Phase 2Results posted
- T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated CancersCompletedNCT02280811Phase 1/2Results posted